ReviewPharmacogenomics and personalized medicine2014

Role of brentuximab vedotin in the treatment of relapsed or refractory Hodgkin lymphoma.

Tanya Siddiqi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.